Vanguard Asset Management »

Vaxcyte shares owned by Vanguard Asset Management

Quarter-by-quarter ownership of Vaxcyte (PCVX) shares owned by Vanguard Asset Management from 13F filings

Historical chart of Vanguard Asset Management investment in Vaxcyte

Tip: Access up to 7 years of quarterly data

All positions including Vaxcyte held by Vanguard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaxcyte by Vanguard Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $6.3M 109k 58.11

More positions owned by Vanguard Asset Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Astrazeneca Ord (AZN)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Johnson & Johnson (JNJ)

View all positions for Vanguard Asset Management

Top funds holding Vaxcyte

Henderson Group
FMR
Vanguard Group
RA Capital Management
T. Rowe Price Investment Management
BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
Wellington Management Company
State Street Corporation
Paradigm Biocapital Advisors
Deep Track Capital
Westfield Capital Management Company
Geode Capital Management
Kynam Capital Management

View all funds holding Vaxcyte